Christopher Lathan, MD, Oncology, Boston, MA, Dana-Farber Cancer Institute

ChristopherScottLathanMDMPH MS

Oncology Boston, MA

Medical Director DFCI Brighton Associate Medical Director Dana-Farber Network Medical oncologist Dana-Farber Cancer Institute Assistant Professor, Harvard Medical School

Dr. Lathan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lathan's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematology/Oncology, 2002 - 2005
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2022
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Options Beyond the First Line for Squamous Cell Carcinoma 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

  • ACCC Seeks to Build a Better Lung Cancer Model
    ACCC Seeks to Build a Better Lung Cancer ModelAugust 11th, 2017
  • Improving Health Your Diagnosis”” Precise and Accurate
    Improving Health Your Diagnosis”” Precise and AccurateMarch 30th, 2017
  • Highs, Lows of Immune Checkpoint Inhibitors
    Highs, Lows of Immune Checkpoint InhibitorsDecember 16th, 2016
  • Join now to see all

Grant Support

  • Racial Disparities In The Treatment Of Lung Cancer In African AmericansNational Cancer Institute2007–2011

Professional Memberships

Hospital Affiliations